Science

We are Engineering the Future of Healthcare. Pioneering genetic medicine that heals patients, protects the planet, and powers progress for all.

Research & Development

Our R&D engine is the cornerstone of our mission, blending deep scientific curiosity with patient-centric outcomes

Technologies & Modalities

We deploy a multimodal toolkit to match the right technology to each therapeutic challenge

Bioevance Genetics Center

Our in-house Bioevance Genetics Center is the UK’s foremost hub for large-scale genomic discovery, combining cutting-edge science with real-world clinical impact

Pioneering Tomorrow’s Cures Today

AI-driven genomics to identify novel disease pathways

1 %
Customer Satisfaction is Our Success

Target Discovery/Translational Excellence: Accelerating lab breakthroughs to Phase I trials in <18 months (industry avg: 3+ years).
Rare Disease Focus: 80% of our pipeline targets conditions with no approved therapies.
Example: Our flagship CRISPR-based therapy for Duchenne MD entered clinical trials in 2023 after record-fast preclinical validation.

Bioevance Genetics Center

Where Discovery Meets Impact”

Harnessing Population Genomics, AI-Driven Target Validation & Diagnostic Synergy to Redefine Precision Medicine.

Pioneering Tomorrow’s Cures Today

Our R&D engine is the cornerstone of our mission, blending deep scientific curiosity with patient-centric outcomes. With a 25-year legacy in genetic medicine, we focus on:

Target Discovery: Leveraging AI-driven genomics to identify novel disease pathways.
Translational Excellence: Accelerating lab breakthroughs to Phase I trials in <18 months (industry avg: 3+ years).
Rare Disease Focus: 80% of our pipeline targets conditions with no approved therapies. Example: Our flagship CRISPR-based therapy for Duchenne MD entered clinical trials in 2023 after record-fast preclinical validation.
The Tools Redefining Genetic Medicine

We deploy a multimodal toolkit to match the right technology to each therapeutic challenge

CRISPR-Cas9 Prime Editing: Safer, more precise gene corrections with <0.1% off-target rates.
mRNA Therapeutics: Next-gen lipid nanoparticles for organ-specific delivery.
Stem Cell Engineering: iPSC-derived tissues for disease modeling and transplant-ready organs.
AI/ML Platforms: Our proprietary GeneForge™ algorithm predicts patient response with 94% accuracy.
Decoding the Future of Precision Medicine

Our in-house Bioevance Genetics Center is the UK’s foremost hub for large-scale genomic discovery, combining cutting-edge science with real-world clinical impact

Analyzed 200,000+ whole genomes from diverse cohorts (including NHS partnerships) to identify novel disease-linked variants.
Proprietary platform GeneSight™ prioritizes high-impact targets with 92% validation success (vs. industry 60%).
Develops companion diagnostics alongside therapies to enable precision dosing.
Partnered with 15+ UK hospitals to integrate genetic testing into routine care.
x

We are always ready to help you at any time, let’s talk together.

Let’s Send Us A Message!

Address: 79 Balsham Road, Harrington NN6 9WT United Kingdom

Support mail: info@bioevance.org

Opening Hours: Mon – Fri: 7.00am – 17.00pm